Exploration of 3-aminoazetidines as triple reuptake inhibitors by bioisosteric modification of 3-α-Oxyazetidine

Minsoo Han, Chiman Song, Nakcheol Jeong, Hoh Gyu Hahn

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

For a development of broad spectrum antidepressant 3-aminoazetidine derivatives, two series of compounds were explored by bioisosteric modification of 3-α-oxyazetidine. We synthesized 166 novel 3-aminoazetidine derivatives in series A and B, starting from Boc-protected 3-azetidinone (3) and Boc-protected 3-azetidinal (9) respectively, through parallel syntheses. The inhibitory reuptake activities against serotonin (5-HT), norepinephrine (NE), and dopamine (DA) neurotransmitters were measured by the Neurotransmitter Transporter Uptake Assay Kit using the human embryonic kidney 293 (HEK293) cells stably transfected with the respective three kinds of human transporters (hSERT, hNET, and hDAT). Our study aimed to identify compounds having relative inhibitory activities against hSERT > hNET > hDAT. Lead optimization including microsomal stability, CYP, hERG assay, Ames test, BBB, and PK study resulted in the identification of compound 10dl as a candidate for further studies.

Original languageEnglish
Pages (from-to)999-1004
Number of pages6
JournalACS Medicinal Chemistry Letters
Volume5
Issue number9
DOIs
Publication statusPublished - 2014 Sep 11

Fingerprint

Assays
Serotonin
Neurotransmitter Transport Proteins
Derivatives
Antidepressive Agents
Neurotransmitter Agents
Dopamine
Norepinephrine
Kidney
2-azetidinone
Lead

ASJC Scopus subject areas

  • Organic Chemistry
  • Drug Discovery
  • Biochemistry

Cite this

Exploration of 3-aminoazetidines as triple reuptake inhibitors by bioisosteric modification of 3-α-Oxyazetidine. / Han, Minsoo; Song, Chiman; Jeong, Nakcheol; Hahn, Hoh Gyu.

In: ACS Medicinal Chemistry Letters, Vol. 5, No. 9, 11.09.2014, p. 999-1004.

Research output: Contribution to journalArticle

@article{ed9e41f4b0c844119cbd7aa6cbfea46b,
title = "Exploration of 3-aminoazetidines as triple reuptake inhibitors by bioisosteric modification of 3-α-Oxyazetidine",
abstract = "For a development of broad spectrum antidepressant 3-aminoazetidine derivatives, two series of compounds were explored by bioisosteric modification of 3-α-oxyazetidine. We synthesized 166 novel 3-aminoazetidine derivatives in series A and B, starting from Boc-protected 3-azetidinone (3) and Boc-protected 3-azetidinal (9) respectively, through parallel syntheses. The inhibitory reuptake activities against serotonin (5-HT), norepinephrine (NE), and dopamine (DA) neurotransmitters were measured by the Neurotransmitter Transporter Uptake Assay Kit using the human embryonic kidney 293 (HEK293) cells stably transfected with the respective three kinds of human transporters (hSERT, hNET, and hDAT). Our study aimed to identify compounds having relative inhibitory activities against hSERT > hNET > hDAT. Lead optimization including microsomal stability, CYP, hERG assay, Ames test, BBB, and PK study resulted in the identification of compound 10dl as a candidate for further studies.",
keywords = "3-aminoazetidines, bioisosterism, Depression, triple reuptake inhibitor",
author = "Minsoo Han and Chiman Song and Nakcheol Jeong and Hahn, {Hoh Gyu}",
year = "2014",
month = "9",
day = "11",
doi = "10.1021/ml500187a",
language = "English",
volume = "5",
pages = "999--1004",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",
number = "9",

}

TY - JOUR

T1 - Exploration of 3-aminoazetidines as triple reuptake inhibitors by bioisosteric modification of 3-α-Oxyazetidine

AU - Han, Minsoo

AU - Song, Chiman

AU - Jeong, Nakcheol

AU - Hahn, Hoh Gyu

PY - 2014/9/11

Y1 - 2014/9/11

N2 - For a development of broad spectrum antidepressant 3-aminoazetidine derivatives, two series of compounds were explored by bioisosteric modification of 3-α-oxyazetidine. We synthesized 166 novel 3-aminoazetidine derivatives in series A and B, starting from Boc-protected 3-azetidinone (3) and Boc-protected 3-azetidinal (9) respectively, through parallel syntheses. The inhibitory reuptake activities against serotonin (5-HT), norepinephrine (NE), and dopamine (DA) neurotransmitters were measured by the Neurotransmitter Transporter Uptake Assay Kit using the human embryonic kidney 293 (HEK293) cells stably transfected with the respective three kinds of human transporters (hSERT, hNET, and hDAT). Our study aimed to identify compounds having relative inhibitory activities against hSERT > hNET > hDAT. Lead optimization including microsomal stability, CYP, hERG assay, Ames test, BBB, and PK study resulted in the identification of compound 10dl as a candidate for further studies.

AB - For a development of broad spectrum antidepressant 3-aminoazetidine derivatives, two series of compounds were explored by bioisosteric modification of 3-α-oxyazetidine. We synthesized 166 novel 3-aminoazetidine derivatives in series A and B, starting from Boc-protected 3-azetidinone (3) and Boc-protected 3-azetidinal (9) respectively, through parallel syntheses. The inhibitory reuptake activities against serotonin (5-HT), norepinephrine (NE), and dopamine (DA) neurotransmitters were measured by the Neurotransmitter Transporter Uptake Assay Kit using the human embryonic kidney 293 (HEK293) cells stably transfected with the respective three kinds of human transporters (hSERT, hNET, and hDAT). Our study aimed to identify compounds having relative inhibitory activities against hSERT > hNET > hDAT. Lead optimization including microsomal stability, CYP, hERG assay, Ames test, BBB, and PK study resulted in the identification of compound 10dl as a candidate for further studies.

KW - 3-aminoazetidines

KW - bioisosterism

KW - Depression

KW - triple reuptake inhibitor

UR - http://www.scopus.com/inward/record.url?scp=84907506775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907506775&partnerID=8YFLogxK

U2 - 10.1021/ml500187a

DO - 10.1021/ml500187a

M3 - Article

AN - SCOPUS:84907506775

VL - 5

SP - 999

EP - 1004

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

SN - 1948-5875

IS - 9

ER -